Cargando…
How to optimize the design and implementation of risk prediction tools: focus group with patients with IgA nephropathy
BACKGROUND: IgA nephropathy (IgAN) is a common type of chronic immune-mediated kidney disease with variable risk of progression to end-stage kidney disease. Risk stratification helps clinicians weight the potential risks and benefits of immunosuppressive therapy for individual patients, and can info...
Autores principales: | Gagliardi, Anna R., Reich, Heather N., Cattran, Daniel C., Barbour, Sean J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493917/ https://www.ncbi.nlm.nih.gov/pubmed/32938443 http://dx.doi.org/10.1186/s12911-020-01253-4 |
Ejemplares similares
-
How Should Pathology Findings Influence Treatment in IgA Nephropathy?
por: Troyanov, Stéphan, et al.
Publicado: (2021) -
Why Target the Gut to Treat IgA Nephropathy?
por: Barratt, Jonathan, et al.
Publicado: (2020) -
The Molecular Phenotype of Endocapillary Proliferation: Novel Therapeutic Targets for IgA Nephropathy
por: Hodgin, Jeffrey B., et al.
Publicado: (2014) -
Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
por: Papasotiriou, Marios, et al.
Publicado: (2022) -
The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)